Carmenpadi (Talk | contribs) |
|||
Line 108: | Line 108: | ||
</figure> | </figure> | ||
<h4>Carmen Padilla</h4> | <h4>Carmen Padilla</h4> | ||
− | <p> | + | <p>Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 124: | Line 124: | ||
</figure> | </figure> | ||
<h4>Melissa González</h4> | <h4>Melissa González</h4> | ||
− | <p> | + | <p>Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 141: | Line 141: | ||
</figure> | </figure> | ||
<h4>Carolina Elizondo</h4> | <h4>Carolina Elizondo</h4> | ||
− | <p class=""> | + | <p class="">Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 157: | Line 157: | ||
</figure> | </figure> | ||
<h4>Jesús García Lima</h4> | <h4>Jesús García Lima</h4> | ||
− | <p> | + | <p>Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 173: | Line 173: | ||
</figure> | </figure> | ||
<h4>Alejandra Vela</h4> | <h4>Alejandra Vela</h4> | ||
− | <p class=""> | + | <p class="">Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 189: | Line 189: | ||
</figure> | </figure> | ||
<h4>Yili Natalia Padilla</h4> | <h4>Yili Natalia Padilla</h4> | ||
− | <p> | + | <p>Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 206: | Line 206: | ||
</figure> | </figure> | ||
<h4>Carlos Vásquez</h4> | <h4>Carlos Vásquez</h4> | ||
− | <p class=""> | + | <p class="">Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 222: | Line 222: | ||
</figure> | </figure> | ||
<h4>Raúl Garza</h4> | <h4>Raúl Garza</h4> | ||
− | <p> | + | <p>Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 239: | Line 239: | ||
</figure> | </figure> | ||
<h4>Melissa Rios</h4> | <h4>Melissa Rios</h4> | ||
− | <p class=""> | + | <p class="">Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 255: | Line 255: | ||
</figure> | </figure> | ||
<h4>Marcelo Álvarez</h4> | <h4>Marcelo Álvarez</h4> | ||
− | <p> | + | <p>Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 269: | Line 269: | ||
</figure> | </figure> | ||
<h4>Suria Itzel Morales</h4> | <h4>Suria Itzel Morales</h4> | ||
− | <p class=""> | + | <p class="">Bioengineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 282: | Line 282: | ||
</figure> | </figure> | ||
<h4>Carlos Frutos</h4> | <h4>Carlos Frutos</h4> | ||
− | <p> | + | <p>Information Technology Engineering</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 296: | Line 296: | ||
</figure> | </figure> | ||
<h4>Javier Naya</h4> | <h4>Javier Naya</h4> | ||
− | <p class="">Physics | + | <p class="">Engineering Physics</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> | ||
Line 309: | Line 309: | ||
</figure> | </figure> | ||
<h4>Javier Montemayor</h4> | <h4>Javier Montemayor</h4> | ||
− | <p>Physics | + | <p>Engineering Physics</p> |
</div> | </div> | ||
<!-- /.team-member--> | <!-- /.team-member--> |
Revision as of 23:07, 19 October 2016
Meet the people who make awesome stuff
Carmen Padilla
Bioengineering
Melissa González
Bioengineering
Carolina Elizondo
Bioengineering
Jesús García Lima
Bioengineering
Alejandra Vela
Bioengineering
Yili Natalia Padilla
Bioengineering
Carlos Vásquez
Bioengineering
Raúl Garza
Bioengineering
Melissa Rios
Bioengineering
Marcelo Álvarez
Bioengineering
Suria Itzel Morales
Bioengineering
Carlos Frutos
Information Technology Engineering
Javier Naya
Engineering Physics
Javier Montemayor
Engineering Physics
Safe Lab Works
During the summer, we worked on the Laboratory of Molecular Diagnosis and Genetic Manipulation, which is at the installations of the FEMSA Biotechnology Center, located at our institution, Tecnológico de Monterrey, Campus Monterrey.
Since it is the first time Acidithiobacillus ferrooxidans and Chromobacterium violaceum are used on a laboratory inside the Center of Biotechnology, our advisors could only give us general guidance on their use. Two of our team members went to the Laboratory of Geomicrobiology of the Institute of Metallurgy of the Autonomous University of San Luis Potosí and were trained by Dr. Viridiana García Meza, so they could learn how to handle Acidithiobacillus ferrooxidans. The risk with this organism lies in the pH of its medium, which is extremely acid. Its handling must be used in an extraction hood and precautions such as using gloves must be taken.
C. violaceum is biosafety level 2 since it can act as an opportunistic pathogen to animals and humans, infecting only immunosuppressed people through skin lesions. Very few cases of this type of infections have been reported. Nevertheless, many of the protocols, such as cell culture and transformation are similar to those from Escherichia coli. Mentoring from Dr. Rodolfo García Contreras, from the Department of Microbiology and Parasitology from the Faculty of Medicine at UNAM was received through phone calls and emails for recommendations of its handling.
Our lab is biosafety level 2, so measurements such as controlled access and decontamination of work surfaces after completion of work. All the rules are established on the Biosafety in Microbiological and Biomedical Laboratories by the Centers for Disease Control and Prevention.
Safe Project Design
Even though one of the organisms we chose as our chassis is listed as biosafety level 2, our project does not present any danger to animals, humans or plants. But, one of the problems in module II, which is the bioleaching by C. violaceum, is the production of cyanide, which is required for the recovery of gold. For this, we designed a cyanide degradation system, where another C. violaceum strain will be modified in order to overexpress cyanide hydratase, a cyanide degradation enzyme.
Due to the complications in fully degrading the cyanide, we must determine the concentration of cyanide left at the end of the process in order to be able to do a proper disposal. This is done according to the NMX-AA-058-SCFI-2001 federal regulation, which establishes the guidelines for the determination of total cyanide in natural, drinking, wastewaters and wastewaters treated. Once this is done, the proper disposal of it must be done, according to the NOM-157-SEMARNAT-2009 federal norm, which establishes the elements and procedures to implement the disposal of mining residues, including cyanide.
References
Centers for disease control and prevention. (2009). Biosafety in Microbiological and Biomedical Laboratories. (5th Edition ed.). United States: HHS Publication.
Norma Oficial Mexicana NOM-157-SEMARNAT-2009. Diario Oficial de la Federación, 30 de agosto de 2011.
Norma Mexicana NMX-AA-058-SCFI-2001. Diario Oficial de la Federación, 09 de julio de 2009.